Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 231 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2784 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2020-08-06 2020-11-28 121891
APO-FAMCICLOVIR 250MG TABLET Resolved 2020-08-19 2021-01-11 122480
APO-MYCOPHENOLATE 250MG CAPSULE Resolved 2020-09-09 2020-12-07 123951
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2020-09-17 2020-09-25 124347
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2020-12-18 2021-01-19 130410
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2021-01-08 2021-01-12 131154
APO-NAPROXEN 250MG TABLET Resolved 2021-02-26 2021-03-24 134820
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2021-02-26 2021-03-19 134823
APO-MYCOPHENOLATE 250MG CAPSULE Resolved 2021-03-26 2021-04-12 136406
APO-NAPROXEN 250MG TABLET Resolved 2021-04-23 2021-06-28 137962
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2021-05-07 2021-06-14 138966
APO-CEFUROXIME 250MG TABLET Resolved 2021-09-17 2021-10-12 145828
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2021-10-01 2021-10-01 146511
APO-AZITHROMYCIN Z 250MG TABLET Resolved 2022-01-07 2022-03-21 152298
APO-DIVALPROEX 250MG TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) Resolved 2022-01-07 2022-02-04 152307
APO-DIVALPROEX 250MG TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) Resolved 2022-02-25 2022-03-24 155603
APO-TERBINAFINE 250MG TABLET Resolved 2022-04-08 2022-06-12 158373
APO-GEFITINIB 250MG TABLET Resolved 2022-04-14 2022-06-24 158819
APO-DIVALPROEX 250MG TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) Resolved 2022-04-29 2022-07-28 159700
APO-AMOXI 250MG POWDER FOR SUSPENSION Resolved 2022-06-17 2024-02-14 162918

Showing 1481 to 1500 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO-ENALAPRIL 5MG TABLET Discontinued 2018-09-07 2018-11-02 60468
APO GLYBURIDE TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-12-14 60518
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-03 71090
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-BROMAZEPAM 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-CIPROFLOX 750MG TABLET Discontinued 2018-09-07 2018-12-28 60388
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497

Showing 321 to 340 of 356